Drug development services including preclinical evaluation (animal and analytical), development, and translation of drug products and technologies that improve healthcare outcomes. Access to equipment and services, such as small animal studies (mice, rats, hamsters), cell culture, material characterization (NGI, Spraytec, Zetasizer), formulation development, dissolution and stability studies, as well as quantitative small molecule HPLC and mass spec analyses.

Dell Medical School’s Health Transformation Research Institute provides leadership and infrastructure to support robust, innovative, and world-class clinical and late-stage (T3-T5) translational research. The Health Transformation Research Institute supports researchers and learners conducting translational investigation, as well as the development of an integrated learning health system in which research is embedded in, drives and reinforces excellence in clinical, educational, and community-focused missions.